Data / Form D filings / LISATA THERAPEUTICS, INC.
LISATA THERAPEUTICS, INC.: Form D filing
LISATA THERAPEUTICS, INC., a biotechnology company in Basking Ridge, NJ, filed a Form D with the SEC in 2026. The latest, on October 2, 2026, reports $351.9 million sold of a $351.9 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 110 ALLEN ROAD SECOND FLOOR, Basking Ridge, NJ, 07920
- Phone
- (908) 229-2590
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 320017
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2 | New notice | $351,903,103 | $351,903,103 | 20 | Sep 17 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| DAVID MAZZO | Executive Officer, Director | |
| JAMES NISCO | Executive Officer | |
| TARIQ IMAM | Executive Officer | |
| GREGORY BROWN | Director | |
| HEIDI HENSON | Director | |
| CYNTHIA FLOWERS | Director | |
| STEVEN KLOSK | Director | |
| MOHAMMAD AZAB | Director | |
| TED LOVE | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15
- Xenon Ophthalmics Inc $3.3 million · Oct 6
Every Form D from the week of Sep 28 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LISATA THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.